Verona Pharma PLC (VRNA)
38.81
+0.95
(+2.51%)
USD |
NASDAQ |
Nov 22, 16:00
38.79
-0.02
(-0.05%)
After-Hours: 20:00
Verona Pharma Free Cash Flow: -103.81M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -103.81M |
| June 30, 2024 | -53.89M |
| March 31, 2024 | -58.07M |
| December 31, 2023 | -50.22M |
| September 30, 2023 | -47.56M |
| June 30, 2023 | -52.93M |
| March 31, 2023 | -51.16M |
| December 31, 2022 | -59.89M |
| September 30, 2022 | -69.48M |
| June 30, 2022 | -28.57M |
| March 31, 2022 | -29.23M |
| December 31, 2021 | -33.27M |
| September 30, 2021 | -34.75M |
| June 30, 2021 | -67.62M |
| Date | Value |
|---|---|
| March 31, 2021 | -50.48M |
| December 31, 2020 | -45.16M |
| September 30, 2020 | -37.70M |
| June 30, 2020 | -36.16M |
| March 31, 2020 | -43.20M |
| December 31, 2019 | -42.92M |
| September 30, 2019 | -37.58M |
| June 30, 2019 | -30.01M |
| March 31, 2019 | -27.33M |
| December 31, 2018 | -23.32M |
| September 30, 2018 | -24.19M |
| June 30, 2018 | -33.86M |
| March 31, 2018 | -32.71M |
| December 31, 2017 | -28.26M |
Free Cash Flow Range, Past 5 Years
-103.81M
Minimum
Sep 2024
-28.57M
Maximum
Jun 2022
-49.80M
Average
-48.89M
Median
Free Cash Flow Benchmarks
| TC BioPharm (Holdings) PLC | -15.84M |
| Adaptimmune Therapeutics PLC | -56.05M |
| Biodexa Pharmaceuticals PLC | -11.12M |
| NuCana PLC | -22.00M |
| Autolus Therapeutics PLC | -205.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -62.66M |
| Cash from Financing (Quarterly) | -7.087M |
| Free Cash Flow Per Share (Quarterly) | -0.7688 |
| Free Cash Flow to Equity (Quarterly) | -62.98M |
| Free Cash Flow to Firm (Quarterly) | -57.49M |
| Free Cash Flow Yield | -3.31% |